← All companies

PMN

ProMIS Neurosciences, Inc.

PMN Nasdaq Pharmaceutical Preparations EDGAR ↗

$14.14

-0.78 -5.23%

Key statistics

from XBRL data in SEC filings

Market cap

$127M

Revenue (TTM)

—

Net income (TTM)

-$40.6M

EPS (TTM)

$-18.60

P/E ratio

—

Dividend yield

—

Free cash flow

-$28.1M

Cash

$63.8M

Total assets

$67.4M

Gross margin

—

52-week range

$6.27 – $27.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure; Other events Jul 28, 2026 8-K Director or officer change; Shareholder vote results May 20, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Results of operations (earnings release) Mar 25, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 30, 2026 8-K Other events Dec 16, 2025 8-K Amended charter or bylaws; Other events Nov 24, 2025 8-K Shareholder vote results Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Director or officer change; Regulation FD disclosure Oct 24, 2025 8-K Director or officer change Sep 30, 2025 8-K Regulation FD disclosure; Other events Sep 3, 2025 8-K Entered a material agreement Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 28, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 22, 2025 8-K Entered a material agreement; Other events Jul 22, 2025 8-K Other events Jul 7, 2025 8-K Director or officer change; Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Regulation FD disclosure Feb 25, 2025 8-K Director or officer change Feb 19, 2025 8-K Regulation FD disclosure Jan 27, 2025 8-K Regulation FD disclosure; Other events Jan 10, 2025 8-K Delisting notice or listing-rule failure Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Shareholder vote results Oct 24, 2024 8-K Director or officer change Oct 10, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Other events Jul 29, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 26, 2024